PDA/FDA Pharmaceutical Supply Chain Conference 2014

The conference with FDA and other regulatory and health authorities and various industrial stakeholders including trade associations will be to identify best practices for protecting patients by securing the end to end pharmaceutical supply chain.

The challenge of securing and protecting the integrity of the vast, global pharmaceutical supply chain can be met through a variety of science- and risk-based approaches. New laws, regulations and guidance continue to evolve helping to stimulate innovation toward enhancing good manufacturing, distribution, and importation practices. Building on earlier PDA/FDA-cosponsored conferences and workshops on pharmaceutical supply chains, this conference will provide a forum to further implementation of innovative approaches to protect the quality of the product to the patient, and to prevent illicit acts such as counterfeiting, diversion, and economic adulteration from threatening the safety of the drug supply. By attending the 2014 PDA/FDA Pharmaceutical Supply Chain Conference you will hear regulators as well as industry experts present on an array of topics addressing practices and approaches to be considered to ensure the integrity and quality of the global pharmaceutical supply chain.